Literature DB >> 11850814

Inhibition of HOS expression and activities by Wnt pathway.

Vladimir S Spiegelman1, Weigang Tang, Masaru Katoh, Thomas J Slaga, Serge Y Fuchs.   

Abstract

BetaTrCP and HOS are closely related F-box proteins, which play key roles in ubiquitination and degradation of beta-catenin and IkappaB through associating with those phosphorylated substrates and recruiting SCF E3 ubiquitin ligase. Here we report that activation of Wnt/beta-catenin signal transduction pathway elevates betaTrCP levels but inhibits expression of HOS in 293T cells. Similar disparity is likely to exist in human colorectal tumors. In the NIH3T3 cells, which express HOS, but not betaTrCP, Wnt/beta-catenin signaling leads to inhibition of HOS promoter activity and NF-kappaB-driven transcription as well as to stabilization of beta-catenin. These results indicate that expression and activities of HOS are negatively regulated by Wnt/beta-catenin pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850814     DOI: 10.1038/sj.onc.1205132

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

Review 1.  Ubiquitination and degradation of the inhibitors of NF-kappaB.

Authors:  Naama Kanarek; Nir London; Ora Schueler-Furman; Yinon Ben-Neriah
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

2.  Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels.

Authors:  Deeba N Syed; Farrukh Afaq; Nityanand Maddodi; Jeremy J Johnson; Sami Sarfaraz; Adeel Ahmad; Vijayasaradhi Setaluri; Hasan Mukhtar
Journal:  J Invest Dermatol       Date:  2011-02-24       Impact factor: 8.551

3.  Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells.

Authors:  J Liu; K G Suresh Kumar; D Yu; S A Molton; M McMahon; M Herlyn; A Thomas-Tikhonenko; S Y Fuchs
Journal:  Oncogene       Date:  2006-09-25       Impact factor: 9.867

4.  Transcriptional Regulation of CRD-BP by c-myc: Implications for c-myc Functions.

Authors:  Felicite K Noubissi; Mikhail A Nikiforov; Nancy Colburn; Vladimir S Spiegelman
Journal:  Genes Cancer       Date:  2010-10

5.  SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.

Authors:  Jianping Jin; Takahiro Shirogane; Lai Xu; Grzegorz Nalepa; Jun Qin; Stephen J Elledge; J Wade Harper
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

6.  Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase.

Authors:  Ying Li; K G Kuresh Kumar; Weigang Tang; Vladimir S Spiegelman; Serge Y Fuchs
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

7.  Raf inhibitor stabilizes receptor for the type I interferon but inhibits its anti-proliferative effects in human malignant melanoma cells.

Authors:  K G Suresh Kumar; Jianghuai Liu; Ying Li; Duonan Yu; Andrei Thomas-Tikhonenko; Meenhard Herlyn; Serge Y Fuchs
Journal:  Cancer Biol Ther       Date:  2007-06-13       Impact factor: 4.742

8.  SCF-mediated Cdh1 degradation defines a negative feedback system that coordinates cell-cycle progression.

Authors:  Hidefumi Fukushima; Kohei Ogura; Lixin Wan; Ying Lu; Victor Li; Daming Gao; Pengda Liu; Alan W Lau; Tao Wu; Marc W Kirschner; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Cell Rep       Date:  2013-08-22       Impact factor: 9.423

9.  The Dynamic Change of Gene-Regulated Networks in Cashmere Goat Skin with Seasonal Variation.

Authors:  Sile Hu; Chun Li; Dubala Wu; Hongyan Huo; Haihua Bai; Jianghong Wu
Journal:  Biochem Genet       Date:  2021-07-24       Impact factor: 1.890

Review 10.  Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis.

Authors:  Masaru Katoh
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 6.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.